Margaret Herridge

In 2007, Herridge co-established the RECOVER program for post-ICU patients at university-affiliated ICUs in Toronto, Hamilton, Ottawa, Montreal, Sherbrooke, and Vancouver.^[3][4] In 2013, Herridge became a Professor of Critical Care and Respiratory Medicine at the University of Toronto and a Section Editor for the European Society of Intensive Care Medicine's Intensive Care Medicine publication.^[2] She received the 2018 Critical Care Lifetime Achievement Award from the American Thoracic Society for "a career devoted to research and teaching of the science and practice of Critical Care Medicine and outstanding service to the Assembly on Critical Care."^[5][6]

During the COVID-19 pandemic, Herridge collaborated with U of T colleague Angela Cheung to establish the Canadian COVID-19 Prospective Cohort study (CanCOV). As the primary investigators, they lead an interdisciplinary team studying the short- and long-term outcomes of COVID-19 patients by examining how genomics, demographics, social factors, and other variables influence disease progression and severity.^[7][8] In recognition of her "international leadership in family and caregiver outcomes after critical illness," Herridge was elected a Fellow of the Canadian Academy of Health Sciences in 2021.^[9]

Herridge was appointed a Tier 1 Canada Research Chair in Critical Illness Outcomes and the Recovery Continuum in 2022.^[10] She also received the 2022 CIHR-ICRH/CCCS Distinguished Lecturer Award in Critical Care Sciences.^[11]

Herridge is married to Robert Stewart, a fellow doctor at St. Michael’s Hospital. After her husband was diagnosed with liver failure in 2021, their friend and colleague Marie Faughnan donated her liver to him.^[12][13]